doi:10.3969/j.issn.1673-8640.2020.08.026

Abstract

CLC Number:

R446.1

. [J]. Laboratory Medicine, 2020, 35(8): 854-856.

Figures/Tables 1

References 7

[1]	国家卫生健康委办公厅. 关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知[EB/OL].(2020-02-01)[2020-03-01]. .
[2]	SCHWARTZ D A,GRAHAM A L. Potential maternal and infant outcomes from(Wuhan)coronavirus 2019-nCoV infecting pregnant women:lessons from SARS,MERS,and other human coronavirus infections[J]. Viruses,2020,12(2):194.
[3]	CHEN D,YANG H,CAO Y,et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus(COVID-19) infection[J]. Int J Gynaecol Obstet,2020,149(2):130-136.
[4]	ZHAO S,LING K,YAN H,et al. Anesthetic management of patients with COVID 19 infections during emergency procedures[J]. J Cardiothorac Vasc Anesth,2020,34(5):1125-1131.
[5]	HUANG C,WANG Y,LI X,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J]. Lancet,2020,395(10223):497-506.
[6]	陈烁,黄博,罗丹菊,等. 新型冠状病毒感染孕妇三例临床特点及胎盘病理学分析[J]. 中华病理学杂志,2020,66(5):418-423.
[7]	ZHU H,WANG L,FANG C,et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia[J]. Transl Pediatr,2020,9(1):51-60.

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 7

Related Articles 15

Recommended Articles

Metrics